ORTEXORTEX News
Tracking IONQ? Get live short interest, options flow, and signals on ORTEX.Sign up free →
IO
Earnings PreviewIONQ

IonQ Short Position Holds Elevated Ground Before Tuesday's Print

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 1 Nov 2026, 04:05

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

IonQ short sellers built their position fast over the past month and have not retreated. Short interest now covers 13.2% of the free float, up 14% over the past month and 11% over the past week, with roughly 46.6 million shares shorted as of October 29. That follows an even steeper weekly accumulation flagged in the previous week's data, when the position grew 16% in seven days. The pace has moderated slightly but the level has not. Borrow availability has tightened to 13.7%, down 29% week-on-week, meaning fewer than fourteen shares are available to borrow for every hundred already lent out. Cost to borrow, at just under 1%, has actually eased 21% over the week despite the tighter lending pool, so squeeze pressure remains limited for now.

The stock has not held up well. It closed at $30.04 on October 30, down 5.3% on the day and 32% over the past month, giving back a significant portion of gains accumulated earlier in the year. Closest peers moved lower on the same day too: RGTI fell 6.7%, LAES dropped 6.4%, and GSIT lost more than 8%, so the sector backdrop is broadly weak, not specific to IonQ.

The analyst community is split on how much of that decline is justified. Morgan Stanley cut its target to $43 from $49 on October 15, maintaining an Equal-Weight rating, while Rosenblatt reduced its target to $70 from $100 on the same day but kept its Buy. The consensus mean target stands near $64, more than double the current price, yet the gap between the most optimistic and most cautious estimates is exceptionally wide. The bull argument centres on IonQ's $1.8 billion cash balance with no debt, its reaffirmed standalone 2026 revenue guidance of $280 to $290 million, and a trapped-ion architecture that proponents argue delivers superior qubit fidelity. Bears point to a quantum computing market that remains commercially early-stage, a revenue mix increasingly weighted toward a lower-multiple foundry business, and ongoing losses in a sector where IBM, Google, and Microsoft can sustain competition with far deeper pockets. IonQ's ORTEX factor scores reflect that tension: it ranks in the 96th percentile on EPS surprise, consistent with a company that has beaten estimates repeatedly, but the short score of 65.6 places it in just the 6th percentile of its universe, one of the more heavily shorted names tracked.

Wikipedia pageview data from the Wikimedia Foundation, the one real-economy signal available for IonQ, shows retail attention running 2.7 standard deviations above the company's own 90-day average as of October 13. That is an attention reading, not a revenue indicator, but elevated retail interest heading into a print with this much short positioning has, in other contexts, amplified the immediate post-earnings move in both directions.

Tuesday's Q3 report will test whether IonQ's revenue trajectory and gross margin profile are consistent with a company commanding a $13 billion market cap while still loss-making, and whether its manufacturing and enterprise contract progress is enough to keep the wide analyst target range anchored to the upside or compress it further.

Stocks in this article

See the live data behind this article on ORTEX.

Open IONQ on ORTEX →

How this article was generated

Generated
1 Nov 2026, 04:26
Data as of
1 Nov 2026, 04:05
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.